Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium

Goyfman, 2017, Combined aquaretic and diuretic therapy in acute heart failure, Int J Nephrol Renovasc Dis, 10, 129, 10.2147/IJNRD.S135660 Salahudin, 2019, Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial, J Pak Med Assoc, 69, 1794 Cooper, 1999, Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction, Circulation, 100, 1311, 10.1161/01.CIR.100.12.1311 Nolan, 1998, Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart), Circulation, 98, 1510, 10.1161/01.CIR.98.15.1510 Macdonald, 2004, What is the optimal serum potassium level in cardiovascular patients?, J Am Coll Cardiol, 43, 155, 10.1016/j.jacc.2003.06.021 Fitzpatrick, 1985, Stability and inter-relationships of hormone, haemodynamic and electrolyte levels in heart failure in man, Clin Exp Pharmacol Physiol, 12, 145, 10.1111/j.1440-1681.1985.tb02317.x Knight, 1979, Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease, Br Heart J, 42, 316, 10.1136/hrt.42.3.316 Palmer, 2011, Metabolic complications associated with use of diuretics, Semin Nephrol, 31, 542, 10.1016/j.semnephrol.2011.09.009 Mentz, 2015, Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure, JACC Heart Fail, 3, 97, 10.1016/j.jchf.2014.09.003 Butler, 2017, Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF Randomized Clinical Trial, JAMA Cardiol, 2, 950, 10.1001/jamacardio.2017.2198 Casals-Stenzel, 1982, Detection and comparative evaluation of aldosterone antagonists in glucocorticoid-treated, adrenalectomized rats, Eur J Pharmacol, 80, 37, 10.1016/0014-2999(82)90175-3 Vasko, 1985, Furosemide absorption altered in decompensated congestive heart failure, Ann Intern Med, 102, 314, 10.7326/0003-4819-102-3-314 ANSM, 2019 Bart, 2012, Ultrafiltration in decompensated heart failure with cardiorenal syndrome, N Engl J Med, 367, 2296, 10.1056/NEJMoa1210357 Lang, 2015, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 16, 233, 10.1093/ehjci/jev014 Gardiner, 1989, Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites, J Clin Pharmacol, 29, 342, 10.1002/j.1552-4604.1989.tb03339.x Lentine, 2017, KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors, Transplantation, 101, S1, 10.1097/TP.0000000000001770 Ponikowski, 2016, Eur J Heart Fail, 18, 891, 10.1002/ejhf.592 Vukadinovic, 2017, True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis, Am Heart J, 188, 99, 10.1016/j.ahj.2017.03.011 Yancy, 2017, J Card Fail, 23, 628, 10.1016/j.cardfail.2017.04.014 Zannad, 2011, Eplerenone in patients with systolic heart failure and mild symptoms, N Engl J Med, 364, 11, 10.1056/NEJMoa1009492 Lopez-de-Sa, 2011, [Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry], Rev Esp Cardiol, 64, 981, 10.1016/j.recesp.2011.06.013 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Rassi, 2013, Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction, J Am Coll Cardiol, 61, 35, 10.1016/j.jacc.2012.08.1019 Bernardi, 1993, Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content, Liver, 13, 156, 10.1111/j.1600-0676.1993.tb00624.x Adamson, 1972, Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration, J Endocrinol, 53, 425, 10.1677/joe.0.0530425 Mills, 1961, The effects of intravenous aldosterone and hydrocortisone on the urinary electrolytes of the recumbent human subject, J Physiol, 156, 415, 10.1113/jphysiol.1961.sp006684 Alexander, 1977, The urinary sodium: potassium ratio and response to diuretics in resistant oedema, Postgrad Med J, 53, 117, 10.1136/pgmj.53.617.117